JCB, Volume 7, Number 3, 2001 Editorial Vol.7 No. 3 (2001) Technology Transfer Karling Alice Leung   Article Vol.7 No. 3 (2001) Turning good science into successful businesses: The technology transfer systems in the UK and Germany Hannah Kettler In the biotechnology industries, the technology transfer process serves as a crucial bridge linking public science to commercial enterprise. This paper argues that a Article Vol.7 No. 3 (2001) Licensing intellectual property William F Lawrence This paper presents an overview of several issues concerning licensing intellectual property in or from the United States. We address (1) circumstances requiring governmen Article Vol.7 No. 3 (2001) The role of technology transfer in biotechnology John Wilkinson Technology transfer is the lifeblood of building a sustainable biotechnology industry. This paper considers the development of the technology transfer industry, and parti Article Vol.7 No. 3 (2001) Royalty rates: Current issues and trends Sharon Finch One of the most intensely debated areas in a negotiation is that of the financial settlement: in particular the royalty rate, which is key, as it directly impacts on the Article Vol.7 No. 3 (2001) Technology transfer in the biomedical sciences: The Medical Research Council approach David A A Owen This paper describes why the UK Medical Research Council participates in exploitation (an integral part of its mission), the objectives for exploitation (primarily to serve public fo Article Vol.7 No. 3 (2001) Pharmaceutical subsidisation and judicial review of the National Institute for Clinical Excellence Richard Best This paper outlines the nature and rules of the National Institute for Clinical Excellence (NICE) and, in the context of pharmaceuticals, assesses whether NICE is subject to judicial Article Vol.7 No. 3 (2001) The consumer marketing of biotechnology Brian Wansink What leads to the different consumer attitudes towards biotechnology? This paper shows how consumers come to accept biotechnology applications and how marketers of biotec Article Vol.7 No. 3 (2001) AMRAD: Pioneer of Australian biotechnology Amanda Caples AMRAD is a biotechnology company in the human healthcare sector. Its drug discovery projects are focused on novel cytokine therapies and small molecule anti-viral treatmen Legal and Regulatory Updates Vol.7 No. 3 (2001) Legal and Regulatory Update John Wilkinson   Legal and Regulatory Updates Vol.7 No. 3 (2001) EU Financial accounts reports David Citron   Legal and Regulatory Updates Vol.7 No. 3 (2001) US Financial accounts reports Glenn Crocker  Â